Clinical Trial Update: A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 in subjects with Type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GZR4

Snippet

Sponsor: Gan and Lee Pharmaceuticals, USA | Conditions: Diabetes | Phase 1 | Status: COMPLETED